Citius Pharmaceuticals, Inc. Quarterly Depreciation in USD from Q4 2016 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Citius Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from Q4 2016 to Q4 2023.
  • Citius Pharmaceuticals, Inc. Depreciation for the quarter ending December 31, 2023 was $578.000, a 20.8% decline year-over-year.
  • Citius Pharmaceuticals, Inc. annual Depreciation for 2023 was $2.67K, a 8.72% decline from 2022.
  • Citius Pharmaceuticals, Inc. annual Depreciation for 2022 was $2.92K, a 95.9% increase from 2021.
  • Citius Pharmaceuticals, Inc. annual Depreciation for 2021 was $1.49K, a 76.8% increase from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $578 -$152 -20.8% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-14
Q4 2022 $730 $0 0% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
Q4 2021 $730 +$577 +377% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-10
Q4 2020 $153 -$24 -13.6% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-10
Q4 2019 $177 -$58 -24.7% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q4 2018 $235 -$407 -63.4% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-13
Q4 2017 $642 -$30 -4.46% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-14
Q4 2016 $672 Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.